Search Results - C. Scheid

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency by F. Jakobs, P. Ahmadi, V. Osterkamp, J. Jeck, U. Holtick, C. Scheid, Florian Kron

    Published in Cost Effectiveness and Resource Allocation (2025-03-01)
    Get full text
    Article


  2. 2

    A Worksite Nutrition Intervention is Effective at Improving Employee Well-Being: A Pilot Study by Jay T. Sutliffe, Mary Jo Carnot, Joel H. Fuhrman, Chloe A. Sutliffe, Julia C. Scheid

    Published in Journal of Nutrition and Metabolism (2018-01-01)
    Get full text
    Article


  3. 3

    Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation by T. Richardson, D. Schütte, K. Feyer, L. Grass, M. Hallek, C. Scheid, F. Simon, T. Braun, M. Fürstenau, P. Gödel, U. Holtick

    Published in Scientific Reports (2024-09-01)
    Get full text
    Article


  4. 4

    Author Correction: Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation by T. Richardson, D. Schütte, K. Feyer, L. Grass, M. Hallek, C. Scheid, F. Simon, T. Braun, M. Fürstenau, P. Gödel, U. Holtick

    Published in Scientific Reports (2025-02-01)
    Get full text
    Article


  5. 5

    P10.01 Nutritional and immunometabolic measures for risk assessment in allogeneic hematopoietic stem cell transplantation by S Theurich, M von Bergwelt-Baildon, M Funk, K Althoff, S Leitzke, U Holtick, C Scheid, D Cordas dos Santos, S Oganesian, H Thurisch

    Published in Journal for ImmunoTherapy of Cancer (2024-03-01)
    Article


  6. 6

    P1069: RETROSPECTIVE COMPARISON OF PATIENT OUTCOMES ON PACRITINIB VERSUS RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS AND THROMBOCYTOPENIA by C. Harrison, P. Bose, R. Mesa, A. Gerds, S. Oh, J.-J. Kiladjian, V. García-Gutierrez, A. Vannucchi, C. Scheid, M. Sobas, S. Verstovsek, S. Buckley, K. Roman-Torres, J. Mascarenhas

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  7. 7

    P879: EXENT AND FLC MASS SPECTROMETRY FOR SEROLOGICAL IDENTIFICATION AND QUANTIFICATION OF MONOCLONAL IMMUNOGLOBULINS IN MULTIPLE MYELOMA by S. Huhn, A. M. Poos, E. K. Mai, M. Hänel, H. J. Salwender, J. Dürig, I. W. Blau, C. Scheid, K. C. Weisel, M. Munder, O. Berlanga, U. Bertsch, H. Goldschmidt, N. Weinhold

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  8. 8

    P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT by P. Borchmann, A. Lohneis, P. Gödel, H. Balke-Want, C. Schmid, F. Ayuk, S. Holtkamp, L. Hanssens, G. Zadoyan, B. Friedrichs, M. Assenmacher, I. Bürger, D. Schneider, T. Overstijns, C. Scheid, U. Holtick, S. Miltenyi, M. Hallek

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  9. 9

    P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESS... by H Einsele, AD Cohen, M Delforge, J Hillengass, H Goldschmidt, K Weisel, M-S Raab, C Scheid, JM Schecter, KC De Braganca, H Varsos, T-M Yeh, L Wang, M Vogel, C Corsale, M Akram, L Pacaud, T Nesheiwat, M Agha, YC Cohen

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  10. 10

    P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES... by J. Hillengass, A. D. Cohen, M. Delforge, H. Einsele, H. Goldschmidt, K. Weisel, M.-S. Raab, C. Scheid, J. M. Schecter, K. C. De Braganca, H. Varsos, T.-M. Yeh, P. Mistry, T. Roccia, C. Corsale, M. Akram, L. Pacaud, T. Nesheiwat, M. Agha, Y. C. Cohen

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  11. 11

    P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA by F. Stegelmann, E. Jahn, S. Koschmieder, F. Heidel, A. Hochhaus, H. Hebart, S. Isfort, A. Reiter, M. Bangerter, C. F. Waller, D. Wolleschak, C. Scheid, J. Göthert, P. Schafhausen, T. Kindler, M. P. Radsak, N. Gattermann, R. Möhle, N. von Bubnoff, A. Schrade, T. Brümmendorf, H. Döhner, M. Griesshammer, K. Döhner

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  12. 12

    C021 | IMPACT ON OUTCOMES OF RESPONSE TO HIGH-DOSE METHOTREXAT-BASED INDUCTION AND CONSOLIDATION REGIMEN IN 1,545 PATIENTS WITH PRIMARY CNS LYMPHOMA TREATED WITH AUTOLOGOUS STEM-CE... by T. Calimeri, M. Fekom, P. Fiore, P. Lopez Pereira, C. Fox, G. Illerhaus, R. Zeiser, K. Cywnarski, H. Ghesquieres, W. Bethge, C. Scheid, D. Richardson, U. Novak, F. Stölzel, M. Trneny, G. Cassanello, A. Mussetti, B. Glass, C. Thieblemont, A. Sureda, A. Bazarbachi, A. J. M. Ferreri

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  13. 13

    P958: REAL-LIFE CURRENT STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSES FROM THE LOCOMMOTION STUDY by H. Einsele, P. Moreau, V. De Stefano, D. Dytfeld, E. Angelucci, R. Benjamin, H. Goldschmidt, N. W. van de Donk, B. Besemer, C. Scheid, R. Vij, E. I. ’. Groen-Damen, M. Semerjian, V. Strulev, J. M. Schecter, T. Roccia, T. Nesheiwat, R. Wapenaar, K. Weisel, M.-V. Mateos

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  14. 14

    P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FRO... by E. K. Mai, U. Bertsch, R. Fenk, D. Tichy, B. Besemer, J. Dürig, R. Schroers, I. von Metzler, M. Hänel, C. Mann, A. M. Asemissen, B. Heilmeier, E. Nievergall, S. Huhn, K. Kriegsmann, N. Weinhold, S. Luntz, T. A. W. Holderrried, K. Trautmann-Grill, D. Gezer, M. Klaiber-Hakimi, M. Müller, C. Khandanpour, W. Knauf, C. Scheid, M. Munder, T. Geer, H. Riesenberg, J. Thomalla, M. Hoffmann, M. S. Raab, H. J. Salwender, K. C. Weisel, H. Goldschmidt

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: